『2 Minutes with Joey - MRK Stock News』のカバーアート

2 Minutes with Joey - MRK Stock News

2 Minutes with Joey - MRK Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Merck (MRK) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • MRK Today - Aug 13: Merck Gets Upgraded

    MRK Today - Aug 13: Merck Gets Upgraded
    2026/08/13
    Hey there! It's Joey here, your go-to guy for stock talk. I’ve been in the investing game for a while, and today, we're checking out Merck, ticker MRK. So, what happened? Merck had a solid day, up about 1.4%. Not too shabby, right?

    Now, let’s break it down. The stock was feeling the love today, and it’s mostly thanks to an upgrade from Daiwa. They gave Merck a little boost, saying it’s looking pretty good. That got people excited, and some jumped on the bandwagon. Plus, it didn’t hurt that Merck's been holding its own against competitors lately. While others were struggling, Merck was out here flexing its muscles.

    Then, there’s the chatter about Keytruda, Merck's big cancer drug. There’s some buzz around whether it can keep the momentum going in the second half of 2026. Folks are curious if it’ll keep driving growth or if they’ll need to find something else to keep the engine running.

    Oh, and just a heads up! One of their big execs, Richard DeLuca, sold off a chunk of shares recently. Not sure what that’s about, but it’s something to keep in mind. It’s always interesting when insiders start moving their shares around.

    All in all, Merck had a nice little pop today, riding high on that upgrade and some solid performance. Just remember, I’m here to keep you informed and entertained, but I’m not giving any financial advice. So, keep it chill, and catch you later!
    続きを読む 一部表示
    1 分
  • MRK Today - Aug 12: Price Target Raised

    MRK Today - Aug 12: Price Target Raised
    2026/08/12
    Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Merck today. So, MRK had a solid day, up about 1.66%. Not too shabby!

    Alright, here’s the scoop. Merck's stock was on the rise, and it seems like there’s a bit of buzz around the company lately. The volume was pretty average, so nothing crazy there. But hey, when you’ve got a stock moving up, it usually means people are feeling good about it, right?

    Now, why the good vibes? Well, a few things are happening. First up, some analysts at Daiwa Securities decided to upgrade Merck, which is always a nice little boost for investor confidence. Plus, there’s a new 12-month price target floating around that’s been raised to $138.29, suggesting there’s still some room to grow. That’s like saying, “Hey, we believe in you!”

    Oh, and let’s not forget about Merck’s plans to expand the use of their RSV treatment, ENFLONSIA, in kids. That’s a big deal! If they can get that going, it could open up a whole new market for them. And speaking of big moves, they’re also pushing forward with that $11.3 billion acquisition of Bio-Techne. That’s a hefty price tag, but if it pays off, it could really bolster their portfolio.

    Looking ahead, it’s worth knowing that Merck’s been on a bit of a roll lately, with their stock up about 5.6% over the past month. So, things are looking pretty positive overall.

    That’s the lowdown on Merck for today! It’s always fun to see how these stocks are moving and what’s shaping their paths. Just remember, I’m here to give you the scoop for fun and info, but I’m not a financial advisor. So, keep that in mind as you’re making your investment moves. Catch you later!
    続きを読む 一部表示
    2 分
  • MRK Today - Aug 11: Slight Dip Despite Upbeat Forecast

    MRK Today - Aug 11: Slight Dip Despite Upbeat Forecast
    2026/08/11
    Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Merck today. So, Merck (MRK) had a bit of a red day, slipping about half a percent. Yeah, it got a little dinged.

    Now, here’s the scoop. The stock opened strong, but then it kinda just floated downwards throughout the day. Nothing too dramatic, but it definitely wasn’t the kind of day we love to see. You know how it goes—sometimes the vibes just aren’t there, even when things look okay on paper.

    So why the dip? Well, there’s some good news floating around, but it seems like it didn’t fully lift the stock. Argus just bumped up their price target for Merck to $145, which is pretty optimistic considering their strong portfolio. They also dropped a positive forecast, saying Merck’s looking good overall. But even with all that sunshine, it seems like the market just didn’t react like you’d expect. Maybe it’s just one of those days where people were feeling cautious and hit the sell button a bit too quick. Who knows?

    Also, a little side note: Merck’s animal health chief, DeLuca, sold over 6,000 shares recently. Not exactly a confidence booster, right? When high-ups start cashing in, it can make folks a bit antsy.

    On the horizon, you might wanna keep an eye on Merck’s upcoming developments in their pipeline. They’ve got some interesting stuff cooking, and that could really shake things up in the future.

    So, to wrap it up, today was a bit of a slow bleed for Merck, even with some positive analyst chatter in the background. Just goes to show, you never really know how the market's gonna react. Remember, this is just info for you to chew on, not financial advice. Catch you later, and happy investing!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません